The Imaging Committee of the ECOG-ACRIN Cancer Research Group is the key entry point for studies of new imaging agents. It develops and conducts trials for early evaluation of new imaging agents and approaches, and plans for their broader application. At least one representative from each disease-oriented committee or working group in the Therapeutic Studies Program is a member. This committee, along with its various working groups, shown below, seeks leaders in imaging, regardless of their institution’s membership status in the Group.
Beth Israel Deaconess Medical Center and Harvard Medical School Teaching Hospital, as well as the Center for Research and Innovation, American College of Radiology